Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 289
Selected: 0
NCT IDTitle
NCT04858594Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy
NCT02845414Study of CD133KDEL Toxin in the Treatment for Solid Tumors
NCT00176904Stem Cell Transplant for Inborn Errors of Metabolism
NCT02991898Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
NCT01105650Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
NCT00369291CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
NCT00882206Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia
NCT01370213NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases
NCT00638547Intrathecal Enzyme Replacement for Hurler Syndrome
NCT00354172Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
NCT00630253Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
NCT04855253Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL
NCT06692426Trial of Cell Based Therapy for DMD
NCT01962636Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
NCT02988843Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
NCT00005987Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma
NCT00176852Stem Cell Transplant for Hemoglobinopathy
NCT05735717MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
NCT04740008Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices
NCT02605421Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
NCT00478244Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
NCT00602693T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
NCT01626092Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
NCT05308316Sugars in Cigarettes
NCT00005998Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT01207076AHN-12 Biodistribution in Advanced Leukemia
NCT00618696Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
NCT00167180Post Transplant Donor Lymphocyte Infusion
NCT05025774Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
NCT06412497MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT01385423Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
NCT00177047Autologous Transplant for Multiple Myeloma
NCT03213964Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
NCT05634512Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
NCT01144442WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
NCT05809557EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT07153016LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer
NCT02999399Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism
NCT00612716Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
NCT06544811American Indian Smokefree Native RCT
NCT00379197Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
NCT01634217Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
NCT04363346Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia
NCT01885897IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
NCT03850691Radiation and Combination Immunotherapy for Melanoma
NCT01171469Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
NCT04284254MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT
NCT01685411Busulfan and Cyclophosphamide Followed By ALLO BMT
NCT01666080Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)